havrix adult injection
glaxosmithkline pharmaceutical kenya limited likoni road industrial area nairobi - hepatitis a vaccine - injection - 1440 eu/ml - viral vaccines: hepatitisvaccines
havrix junior injection
glaxosmithkline pharmaceutical kenya limited likoni road industrial area nairobi - hepatitis a vaccine - injection - 720 eu/0.5 ml - viral vaccines: hepatitisvaccines
hepatitis b vaccine (rdna) (adult) suspension for injection
serum institute of india ltd. 212/2 hadapsar pune 411028 india - hepatitis b vaccine (rdna) (adult) - suspension for injection - each dose of 1 ml contains purified hepatitis b - viral vaccines: hepatitisvaccines
hepatitis b vaccine (rdna) (paediatric) suspension for injection
serum institute of india ltd. 212/2 hadapsar pune 411028 india - hepatitis b vaccine (rdna) (paediatric) - suspension for injection - each dose of 0.5 ml contains purified hepatitis - viral vaccines: hepatitisvaccines
revac-b+ suspension for injection
bharat biotech international limited genome valley shameerpet mandal hyderabad - hepatitis b vaccine (rdna pichia pastoris) - suspension for injection - 10 mcg / 0.5 ml - viral vaccines: hepatitisvaccines
shanvac b suspension for injection
sanofi pasteur s.a. 2 avenue pont pasteur 69007 lyon - hepatitis-b vaccine (r-dna) - suspension for injection - rdna hepatitis b surface antigen purified - viral vaccines: hepatitisvaccines
twinrix adult vaccine suspension for injection
glaxosmithkline pharmaceutical kenya limited p.o box 78392-00507 nairobi kenya - combined inactivated hepatitis a and rdna - suspension for injection - >720 eu & 20 mcg/ml respectively - viral vaccines: hepatitisvaccines
twinrix paediatric vaccine suspension for injection
glaxosmithkline pharmaceutical kenya limited likoni road industrial area nairobi - combined inactivated hepatitis a and rdna - suspension for injection - >360 eu & 10 mcg / 0.5 ml respectively - viral vaccines: hepatitisvaccines
avaxim 80 u pediatric
sanofi israel ltd - hepatitis a vaccines - suspension for injection - hepatitis a vaccines 80 units / 0.5 ml - hepatitis a, inactivated, whole virus - hepatitis a, inactivated, whole virus - avaxim 80 u pediatric is indicated for active immunisation against infection caused by hepatitis a virus in children aged from 12 months to 15 years inclusive, who are at risk either of contaminating or spreading infection or of a life threatening disease if infected.
vaqta 25 u 0.5 ml
merck sharp & dohme (israel - 1996) company ltd, israel - hepatitis a virus antigen, inactivated - suspension for injection - hepatitis a virus antigen, inactivated 25 units / 0.5 ml - hepatitis a, inactivated, whole virus - hepatitis a, inactivated, whole virus - vaqta is indicated for active pre-exposure prophylaxis against disease caused by hepatitis a virus in children and adolescents 12 months of age and older .